Humanity’s Next Big Leap- A TB-Free Future.

It’s time to DisrupTB to End TB.

Pioneer a movement that matters.

Our forward-thinking design approach.

Embrace radical change. We need to address chronic barriers and challenges from new angles and fresh perspectives.

Challenge vested interests and legacy structures. We need to change long-established power dynamics, systems, and practices.

Learn more about our work

Synergize private sector best practices with public sector goals. We need to apply effective business strategies and entrepreneurial models for public sector contexts.

Our cutting-edge solution Innoscan.

A comprehensive, searchable, and interactive dataset of all existing and upcoming innovations (products, services, processes) that can be applied to airborne infectious diseases.

Explore Innoscan

Ending TB is a chance to make history.

TB is a preventable, treatable, and curable disease, but it is currently the world’s deadliest infectious disease, surpassing COVID-19, HIV, and malaria. According to the World Health Organization’s (WHO) Global Tuberculosis Report, in 2022 alone, there were 1.3 million deaths from TB and as many as 10.6 million people falling ill with the disease.

There is a rich innovation pipeline to end TB, including 16 vaccine candidates, diagnostic tests, treatment for TB, including a diverse range of digital- and AI-based solutions.

However, investment in TB has remained largely unchanged in the last two decades and more investment is needed to ensure these innovations reach the maximum number of people.

Ending TB by 2030 is feasible and doable by Re-imagining TB Care.